J B Chemicals & Pharmaceuticals has allotted 37,84,100 equity shares under ESOS on 21 January 2026. Consequently, the issued, subscribed and paid-up capital has increased from 15,66,50,956 equity shares of Re. 1 each to 16,04,35,056 equity shares of Re. 1 each. Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 21.79% to Rs 197.89 crore in the quarter ended December 2025 as against Rs 162.49 crore during the previous quarter ended December 2024. Sales rose 10.51% to Rs 1064.72 crore in the quarter ended December 2025 as against Rs 963.49 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1064.72963.49 11 OPM %27.7826.42 - PBDT312.22259.93 20 PBT266.87217.99 22 NP197.89162.49 22 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 January 2026.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 2,500 equity shares under ESOS on 06 December 2025. Consequently, the issued, subscribed and paid-up capital has increased from 15,66,48,456 equity shares of Re. 1 each to 15,66,50,956 equity shares of Re. 1 each. Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 19.05% to Rs 207.82 crore in the quarter ended September 2025 as against Rs 174.57 crore during the previous quarter ended September 2024. Sales rose 8.42% to Rs 1084.90 crore in the quarter ended September 2025 as against Rs 1000.62 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1084.901000.62 8 OPM %28.5427.04 - PBDT323.59278.41 16 PBT279.15236.53 18 NP207.82174.57 19 Powered by Capital Market - Live News